<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>EIN News: Central &amp; Eastern Europe Pharmaceuticals News</title>
<link>http://www.einnews.com/central-eastern-europe/newsfeed-cee-pharmaceuticals</link><description>Constantly updated news and information about world affairs.</description><item>
<title>ALTADIS : IMPERIAL TOBACCO GROUP PLC INTERIM MANAGEMENT STATEMENT</title>
<link>http://www.einnews.com/news.php?wid=180019773</link>
<pubDate>24 Jul 2008 09:04 GMT</pubDate>
<description>
...  number of markets across the region including Poland, Austria, Finland and Slovakia. Additionally, we made further progress in the  ...  fine cut tobacco sector, particularly in the Czech Republic and in Hungary. In Asia Pacific,  ...
</description>
</item><item>
<title>Research and Markets: By 2012 Pharmaceutical Growth inside Poland Should Hit Almost 6% in Nominal Terms According To Report ?</title>
<link>http://www.einnews.com/news.php?wid=180002815</link>
<pubDate>24 Jul 2008 06:59 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Exports figures improve by 7c in May</title>
<link>http://www.einnews.com/news.php?wid=180000936</link>
<pubDate>24 Jul 2008 06:53 GMT</pubDate>
<description>
...  in US dollars because the Irish manufacturing industry is dominated by US-owned firms. So, according  ...  chemical materials rose by 47pc, medical and pharmaceutical products by 8pc and electrical machinery by  ...  7pc, to Russia by 20pc and to Poland by 39pc. Imports fell by 5pc in  ...
</description>
</item><item>
<title>Glaxo deal opens way for Aspen to grow</title>
<link>http://www.einnews.com/news.php?wid=180000806</link>
<pubDate>24 Jul 2008 06:52 GMT</pubDate>
<description>
...  clinched a licensing and distribution deal with pharmaceutical giant GlaxoSmithKline that will see its products  ...  markets Aspen does not reach, such as eastern Europe. Glaxo will sell the generics, made by  ...  distribution footprint, he said. Aspen already had business interests in SA, Australasia, India, East Africa,  ...
</description>
</item><item>
<title>Pfizer earnings boosted by prescription drugs sales and cost-cutting</title>
<link>http://www.einnews.com/news.php?wid=179973096</link>
<pubDate>24 Jul 2008 02:30 GMT</pubDate>
<description>
...  chief executive of Pfizer, said that the company planned to increase sales volumes in emerging  ...  emerging markets, namely countries in Latin America, eastern Europe, and Asia. The world&apos;s largest drugs maker  ...  US. Pfizer, along with many other big pharmaceuticals companies, has been fighting increasing generic competition  ...
</description>
</item><item>
<title>Keeping in step with focus on off-patent medicines</title>
<link>http://www.einnews.com/news.php?wid=179973094</link>
<pubDate>24 Jul 2008 02:30 GMT</pubDate>
<description>
...  a trend during recent years by large pharmaceutical companies to diversify into off-patent medicines, writes  ...  of France is bidding for control of Czech-based Zentiva, emphasising profits and important growth by  ...  important growth by generics in eastern and central Europe. And Fresenius of Germany this month published  ...
</description>
</item><item>
<title>A whole world in their hands as Chinese warm to Chelsea&apos;s masterplan</title>
<link>http://www.einnews.com/news.php?wid=179968475</link>
<pubDate>24 Jul 2008 01:37 GMT</pubDate>
<description>
...  last night as they took on Guangzhou Pharmaceutical. The previous evening, around 100 highly excited  ...  the big kick-off on August 16... Arsenal Hungary (1 game), Austria (1 game), Germany (1  ...  Scotland (1 game) Liverpool Switzerland (1 game), Poland (1 game), Germany (1 game), Spain (1  ...
</description>
</item><item>
<title>Weak dollar, surge in foreign sales boost second-quarter results as drugmakers beat forecasts</title>
<link>http://www.einnews.com/news.php?wid=179934072</link>
<pubDate>23 Jul 2008 20:53 GMT</pubDate>
<description>
...  and Wyeth show a common theme among pharmaceutical companies - nearly all the growth they&apos;re  ...  &quot;Everything we&apos;re seeing now in the pharmaceutical industry has to do with three things -  ...  revenue in emerging markets in Latin America, Eastern Europe and parts of Asia, where analysts see  ...
</description>
</item><item>
<title>Weak dollar, foreign sales boost drugmakers</title>
<link>http://www.einnews.com/news.php?wid=179932156</link>
<pubDate>23 Jul 2008 20:51 GMT</pubDate>
<description>
...  and Wyeth show a common theme among pharmaceutical companies - nearly all the growth they&apos;re  ...  &quot;Everything we&apos;re seeing now in the pharmaceutical industry has to do with three things -  ...  revenue in emerging markets in Latin America, Eastern Europe and parts of Asia, where analysts see  ...
</description>
</item><item>
<title>Weak dollar, surge in foreign sales boost second - quarter results as drugmakers beat forecasts</title>
<link>http://www.einnews.com/news.php?wid=179931856</link>
<pubDate>23 Jul 2008 20:50 GMT</pubDate>
<description>
...  States. &quot;Everything we&apos;re seeing now in the pharmaceutical industry has to do with three things   ...  revenue in emerging markets in Latin America, Eastern Europe and parts of Asia, where analysts see  ...
</description>
</item><item>
<title>Analysis: Generic drug producers are bulking up</title>
<link>http://www.einnews.com/news.php?wid=179917512</link>
<pubDate>23 Jul 2008 19:18 GMT</pubDate>
<description>
...  convergence with its traditional rival, the innovative pharmaceutical sector. Traditionally, pharmaceutical groups developing patented medicines  ...  consortium to buy control of Zentiva, a Czech generic drugs manufacturer, as it expands its  ...  it expands its franchise into eastern and central Europe, where generics are an important and profitable  ...
</description>
</item><item>
<title>GSK keeps in step with focus on off-patent medicines</title>
<link>http://www.einnews.com/news.php?wid=179912375</link>
<pubDate>23 Jul 2008 18:31 GMT</pubDate>
<description>
...  a trend during recent years by large pharmaceutical companies to diversify into off-patent medicines. Many  ...  of France is bidding for control of Czech-based Zentiva, emphasising profits and important growth by  ...  important growth by generics in eastern and central Europe. And Fresenius of Germany this month published  ...
</description>
</item><item>
<title>By 2012 Pharmaceutical Growth inside Poland Should Hit Almost 6% in Nominal Terms According To Report &apos;Poland Pharmaceuticals and Healthcare Report Q3 2008&apos;</title>
<link>http://www.einnews.com/news.php?wid=179905738</link>
<pubDate>23 Jul 2008 17:54 GMT</pubDate>
<description>
...  with generics, at the expense of patented pharmaceuticals, and the possibility of even more stringent  ...  activity, this quarter has been quiet, with Hungary&apos;s Richter still digesting Polish drug maker Polpharma  ...  position and are stifling free competition. Meanwhile, Poland has slipped two places to joint 11th  ...
</description>
</item><item>
<title>Merck Serono Receives European Approval For Broader Usage Of Erbitux In Metastatic Colorectal Cancer Including 1st-Line Treatment</title>
<link>http://www.einnews.com/news.php?wid=179897367</link>
<pubDate>23 Jul 2008 16:53 GMT</pubDate>
<description>
...  in 73 countries so far: Argentina, Australia, Belarus, Canada, Chile, China, Colombia, Costa Rica, Croatia,  ...  South Africa, South Korea, Switzerland, Taiwan, Thailand, Ukraine, Uruguay, the US, and Venezuela for use  ...  Serono is the division for innovative prescription pharmaceuticals of Merck, a global pharmaceutical and chemical  ...
</description>
</item></channel>
</rss>
